Table 3 Distribution of detailed regimens among RIC patients.

From: Myeloablative conditioning in cord blood transplantation for acute myeloid leukemia patients is efficacious only until age 55

Category

Regimens

N = 1353

FLU/BU based

FLU/BU2 + lowTBI

138 (10.2%)

 

FLU/BU2/MEL

88 (6.5%)

 

FLU/MEL + BU + CA

27 (2.0%)

 

FLU/BU2

23 (1.7%)

 

Others

43 (3.2%)

FLU/CY based

FLU/CY + lowTBI

166 (12.3%)

 

FLU/CY

26 (1.9%)

 

Others

19 (1.4%)

FLU/MEL based

FLU/MEL + lowTBI

495 (36.6%)

 

FLU/MEL

114 (8.4%)

 

FLU/MEL + lowTBI + CA

69 (5.1%)

 

FLU/MEL + CA

44 (3.3%)

 

Others

8 (0.6%)

FLU + others

FLU + others

39 (2.9%)

Others

 

54 (4.0%)

  1. FLU fludarabine, BU busulfan, lowTBI low dose total body irradiation, MEL melphalan, CA cytarabine, CY cyclophosphamide.
Back to article page